Home » Newsletters » BioWorld

BioWorld

Nov. 3, 1999

View Archived Issues

Gilead's Stock Falls Following Panel Decision On HIV Drug

High-Pressure Gene Therapy Prevented Atherosclerotic Recurrence In Arterial Bypass

Other News To Note

European Patent Disclosures

Maxim Raises Another $20M To Fund Studies Of Maxamine

Scios Licenses FGF To Chiron In $24.5M Angiogenic Alliance